Emilio Clementi

Scopus Author ID ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 20

Top Topics

Machine Learning

Community Dwelling

Loop Mediated Isothermal Amplification

Mild Cognitive Impairment

Top Venues

Journal of neurology

Expert review of clinical pharmacology

The pharmacogenomics journal

This page only lists publications with an associated author ORCID identifier.

Publications

Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology 17 (5-6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology 17 (5-6) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Stefania Cheli, Diego Savino, Annalisa De Silvestri, Lorenzo Norsa, Naire Sansotta, Francesca Penagini, Dario Dilillo, Roberto Panceri, Dario Cattaneo, Emilio Clementi, Giovanna Zuin
One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study. The pharmacogenomics journal (2023)
Matteo Giovarelli, Anais Serati, Silvia Zecchini, Fabiola Guelfi, Emilio Clementi, Chiara Mandò
Cryopreserved placental biopsies maintain mitochondrial activity for high-resolution respirometry. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Stefania Cheli, Diego Savino, Annalisa De Silvestri, Lorenzo Norsa, Naire Sansotta, Francesca Penagini, Dario Dilillo, Roberto Panceri, Dario Cattaneo, Emilio Clementi, Giovanna Zuin
Correction to: One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study. The pharmacogenomics journal (2023)
Carla Carnovale, Cristiana Perrotta, Sara Baldelli, Dario Cattaneo, Cristina Montrasio, Silvia S Barbieri, Giulio Pompilio, Chiara Vantaggiato, Emilio Clementi, Marco Pozzi
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovascular research (2022)
Carla Carnovale, Marta Gentili, Stefania Antoniazzi, Emilio Clementi, Sonia Radice
Levetiracetam-induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database. Muscle & nerve 56 (6) (2017)
Marco Pozzi, Sara Galbiati, Federica Locatelli, Emilio Clementi, Sandra Strazzer
Performance of a tracheostomy removal protocol for pediatric patients in rehabilitation after acquired brain injury: Factors associated with timing and possibility of decannulation. Pediatric pulmonology 52 (11) (2017)
Emma Assi, Davide Cervia, Laura Bizzozero, Annalisa Capobianco, Sarah Pambianco, Federica Morisi, Clara De Palma, Claudia Moscheni, Paolo Pellegrino, Emilio Clementi, Cristiana Perrotta
Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment. Mediators of inflammation 2015 (2015)